Literature DB >> 16004856

Population strategies to treat hypertension.

Daniel T Lackland1.   

Abstract

The risks of cardiovascular disease, cerebrovascular disease, peripheral artery disease, and end-stage renal disease are linearly related to systolic blood pressure. As the population ages and the prevalence of high blood pressure increases, the implementation of population-based strategies will be essential to reduce the burden of hypertension-related diseases. Reduction and control of elevated blood pressure can effectively slow the progression of end-stage renal disease, cerebrovascular disease, peripheral vascular disease, and cardiovascular disease. The strategies for population-based hypertension control are implemented through an increased awareness of the newest guidelines. In the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, the strategies include lifestyle modification and antihypertensive medication. Although specific blood pressure levels determine antihypertensive medications, lifestyle modifications are advised for all segments of the population and for all blood pressure levels. In particular, lifestyle modification is the recommended intervention for the "prehypertension" category and is encouraged for individuals with normal blood pressure. Also, strategies for lifestyle modifications are part of the treatment strategies for stage 1 and stage 2 hypertension categories in conjunction with antihypertensive medications. The major lifestyle modifications to reduce and manage blood pressure include weight management, incorporation of specific diet plans, dietary sodium reduction, physical activity, and moderation of alcoholic consumption. The implementation and commitment to these strategies can effectively and significantly reduce blood pressure levels, and subsequent hypertension-related disease risks in the population.

Entities:  

Year:  2005        PMID: 16004856     DOI: 10.1007/s11936-005-0036-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  32 in total

Review 1.  Dietary sodium chloride and potassium have effects on the pathophysiology of hypertension in humans and animals.

Authors:  L Tobian
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

2.  Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).

Authors:  Edgar R Miller; Thomas P Erlinger; Deborah R Young; Megan Jehn; Jeanne Charleston; Donna Rhodes; Sharmeel K Wasan; Lawrence J Appel
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

3.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

Review 4.  The salt epidemic: old and new concerns.

Authors:  C Zoccali; F Mallamaci
Journal:  Nutr Metab Cardiovasc Dis       Date:  2000-06       Impact factor: 4.222

Review 5.  The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%.

Authors:  Oscar H Franco; Luc Bonneux; Chris de Laet; Anna Peeters; Ewout W Steyerberg; Johan P Mackenbach
Journal:  BMJ       Date:  2004-12-18

Review 6.  The INTERSALT Study: background, methods, findings, and implications.

Authors:  J Stamler
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

7.  The DASH diet enhances the blood pressure response to losartan in hypertensive patients.

Authors:  Paul R Conlin; Thomas P Erlinger; Arline Bohannon; Edgar R Miller; Lawrence J Appel; Laura P Svetkey; Thomas J Moore
Journal:  Am J Hypertens       Date:  2003-05       Impact factor: 2.689

Review 8.  Alcohol and cardiovascular disease--more than one paradox to consider. Alcohol and hypertension--does it matter? (no!).

Authors:  Gregory Y H Lip; D Gareth Beevers
Journal:  J Cardiovasc Risk       Date:  2003-02

Review 9.  Obesity, sleep apnea, and hypertension.

Authors:  Robert Wolk; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

10.  Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control.

Authors:  Laura P Svetkey; Denise G Simons-Morton; Michael A Proschan; Frank M Sacks; Paul R Conlin; Davis Harsha; Thomas J Moore
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-07       Impact factor: 3.738

View more
  4 in total

Review 1.  Reduction of risk for cardiovascular disease in children and adolescents.

Authors:  Stephen R Daniels; Charlotte A Pratt; Laura L Hayman
Journal:  Circulation       Date:  2011-10-11       Impact factor: 29.690

Review 2.  Dietary salt restriction and blood pressure in clinical trials.

Authors:  Daniel T Lackland; Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

3.  Efficiency or equity? Simulating the impact of high-risk and population intervention strategies for the prevention of disease.

Authors:  Jonathan M Platt; Katherine M Keyes; Sandro Galea
Journal:  SSM Popul Health       Date:  2016-11-19

4.  Household Air Pollution and Blood Pressure, Vascular Damage, and Subclinical Indicators of Cardiovascular Disease in Older Chinese Adults.

Authors:  Thirumagal Kanagasabai; Wuxiang Xie; Li Yan; Liancheng Zhao; Ellison Carter; Dongshuang Guo; Stella S Daskalopoulou; Queenie Chan; Paul Elliott; Majid Ezzati; Xudong Yang; Gaoqiang Xie; Frank Kelly; Yangfeng Wu; Jill Baumgartner
Journal:  Am J Hypertens       Date:  2022-02-01       Impact factor: 2.689

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.